(MENAFN-EIN Presswire)

Dialysis Concentrates Market

Dialysis Concentrate by Type, Application and Dialysis Site: Global Opportunities Analysis and Industry Forecast, 2021-2030.

PORTLAND, OREGON, USA, July 22, 2022 /EINPresswire.com/ — The dialysis concentrates market was valued at $2.69 billion in 2020 and is expected to reach $4.53 billion by 2030, recording a CAGR of 5.40% from 2021 to 2030. Dialysis concentrate is any fluid used in the application of dialysis that includes glucose, electrolyte and purified water. The electrolyte solution is prepared to match the concentration naturally present in the blood. The dialysis solution is prepared according to the patient’s needs, which helps regulate the electrolyte and maintain an acid-base balance to facilitate the procedure of eliminating metabolic excreta from the body. The Dialysis Concentrate is specially formulated based on patients’ needs for regulating the body’s electrolyte balance, acid-base balance, and elimination of metabolic wastes. The concentrated hemodialysis solution is made at precise PH value and is very efficient in operation. Dialysis concentrate rectifies the composition of uremic blood and brings it to the physiological level. It is achieved by reducing the uremic toxic concentration and correcting abnormalities associated with electrolytes and acids.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Major market players profiled in the report are Asahi Kasei Medical Co. Ltd, B. Braun Melsungen AG, Baxter International Inc., Dialysis Medical Solutions, Farmasol, Fresenius Medical Care, Hemoclean, Medites Pharma, spol. sro, Nikkiso and Nipro Renal Solutions.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭

𝐆𝐞𝐭 𝐔𝐩 𝐓𝐨 𝟏𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭, 𝐓𝐢𝐥𝐥 𝐭𝐡𝐞 𝐃𝐚𝐭𝐞 𝟐𝟎𝐭𝐡 𝐨𝐟 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟐.

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

COVID-19 is a large family of viruses that causes illnesses ranging from the common cold to more serious respiratory illnesses. The COVID-19 pandemic has had a negative impact on the industry, as the concern over the transmission of infectious diseases during the dialysis procedure is high.

The global dialysis concentrates market is segmented on the basis of type, application, dialysis site and region. By type, it is divided into acid concentrates, bicarbonate concentrates and peritoneal dialysis fluid. The acid concentrate segment was the major shareholder in 2020, owing to the fact that there is an increase in the adoption of acid concentrate in the treatment of acute and chronic renal failure during hemodialysis.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲

By application, it is divided into hemodialysis and peritoneal dialysis. The hemodialysis segment dominated the global market in 2020 and is expected to continue this trend during the forecast period. This is attributed to the increasing geriatric population and incidence of kidney disease, particularly end-stage renal disease (ESRD) worldwide, as well as the increasing incidence of diabetes and hypertension and shortage of kidneys for transplantation, which increase the use of hemodialysis and hemodialysis concentrate.

Based on the dialysis site, it is categorized into hospital, clinics and dialysis centers and home dialysis. The segment of dialysis clinics and centers acquired the largest share in 2020 and is expected to remain dominant during the forecast period. This is attributed to the benefits of in-center dialysis such as the patients need no medical training as the medical professionals perform the majority of the tasks making it convenient for the patients avoiding any mistakes during the treatment .

Asia-Pacific accounted for the largest share of the global dialysis concentrates market in 2020 and is expected to remain dominant during the forecast period. This has been attributed to increasing cases of ESRD, CKD, diabetes, and hypertension associated with increased rates of diagnosis in Asia-Pacific. Furthermore, increasing number of HD and PD procedures in emerging economies, such as India and China, is the major factor driving the market growth in the region.

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

• Based on type, the acid concentrates segment held the largest global market share in 2020.
• Based on applications, hemodialysis segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By dialysis site, the segment of dialysis clinics and centers dominated the global market in 2020 and is expected to continue this trend during the forecast period.
• Based on region, Asia-Pacific is expected to experience the highest growth rate, registering a CAGR of 6.50% during the forecast period.

𝐖𝐞 𝐚𝐥𝐬𝐨 𝐎𝐟𝐟𝐞𝐫𝐬 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐮𝐧𝐭𝐫𝐲 𝐑𝐞𝐩𝐨𝐫𝐭𝐬-

North America Dialysis Concentrates Market
Dialysis concentrates market in Japan
Dialysis concentrates market in South Korea
Dialysis concentrates market in Singapore
Australia Dialysis Concentrates Market
Dialysis concentrates market in Europe
Dialysis concentrates market in China
Dialysis concentrates market in Indonesia
Taiwan Dialysis Concentrates Market

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬

Market FDC Netupitant-Palonosetron

Digital Radiology/X-Ray Market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 :

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services in 11 industry sectors, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior executives from leading companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

David Correa
Allied Analytics LLP
800-792-5285
write to us here
Visit us on social media:
Facebook
Twitter
LinkedIn

MENAFN22072022003118003196ID1104574009


Legal disclaimer: MENAFN provides the information “as is” without warranty of any kind. We assume no responsibility for the accuracy, content, images, videos, licensing, completeness, legality or reliability of any information in this article. If you have any complaints or copyright issues related to this article, please contact the provider above.